Leaning Objective
Upon completion of this activity, you should be able to:
- Discuss the overall impact of remote hemodynamic monitoring on heart failure patient care, including potential improvements and challenges.
Faculty
JoAnn Lindenfeld, MD, FACC (Co-Chair)
Professor of Medicine
Vanderbilt University Medical Center
Disclosure
Consultant Fees/Honoraria: Abbott, Abiomed, Alleviant, AskBio, Boston Scientific, Cordio, CVRx, Edwards, Intershunt Technologies, Kestra, Merck, Merck & Co, Inc, Orchestra Biomed, Pulnova, Tenax, Vectorious, Volumetrix, VWAVE, WhiteSwell
Target Audience
The target audience for this education includes cardiologists, nurse practitioners, heart failure specialists, electrophysiologists, interventional and invasive cardiologists, and CV care team members.
Important Dates
Date of Release: May 5, 2026
Term of Approval/Date of Expiration: May 5, 2027
Acknowledgement
Educational support for this activity provided by Abbott.